Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
0.2%
1w
8.5%
1m
11.6%
3m
23.4%
6m
44.2%
1y
44.9%
all
5.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 442 0.2%
393
587
Company Overview

Sales
1,179 Cr
Growth: 52.6%
Profit after Tax
352 Cr
Growth: -1.7%
Mid Cap
7,660 Cr
P/E: 21.7x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 1,179
Growth 52.6%
EBITDA 37.3%
P/S 6.5x
Dividend 0.2%
P/E 21.7x
Book Value ₹ 73.6
PEG Ratio 0.4x
ROE 30.2%
P/B 6.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)